Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
DairyX Is Paving the Way to Making Stretchy, Protein-rich, Dairy Cheese - Cow-free
-
OncoC4 and AcroImmune Announce Merger
-
New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement
-
Atavistik Bio Appoints Oncology Clinical Development Leader Mohammad Hirmand, M.D. to Board of Directors
-
Mevion Celebrates 20 Years of Innovation and Showcases the Future of Proton Therapy at ASTRO 2024
-
Samsung Biologics launches development platforms for enhanced therapeutic efficacy
-
Presenting on the Emerging Growth Conference 75 Day 2 on September 26
-
SES AI to Present at AI and EV Battery Industry Conferences to Share Exciting Progress on Its New “All-in on AI” Initiative
-
Engine Capital Comments on Dye & Durham’s Decision to Unduly Delay Special Meeting to December
-
KKR Releases “An Alternative Perspective: Past, Present, and Future”
-
Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the European Academy of Dermatology and Venereology (EADV) 2024 Congress
-
THOR Financial Technologies Launches THOR Index Rotation ETF (THIR)
-
Leaf Space Secures Contract with Maritime Launch Services to Install New Ground Station at Spaceport Nova Scotia
-
Seth Farbman, Chairman of VStock Transfer, to Speak at Lytham Partners Fall 2024 Investor Conference on IPO Markets
-
Southland Awarded $132 million Water Treatment Plant Project for the Bureau of Reclamation
-
BPGbio and Joslin Diabetes Center Announce Publication Showing Game-Changing Effects of Blue Light in the Reduction of Fat Cells
-
Septerna Marks Transition to a Clinical-Stage Company with Appointments of Industry Veterans in Key Drug Development Roles
-
Steakholder Foods® Signs Commercial Sales Agreement for its Plant-Based Premixes with Bondor Foods
-
Eightco Announces $100 million Revenue Forecast – Releases 2025 Strategic Plan
-
Abiologics Strengthens Leadership Team with Appointment of Maria-Chiara Magnone as Chief Scientific Officer
-
Archaeologists Discover Ancient, Pillared Halls at Pañamarca, Peru, including the Painted Throne Room of a Powerful Moche Woman Associated with the Moon Goddess
-
Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day
-
Climb Channel Solutions Announces A-LIGN, Security and Compliance Partner, as Global Contract
-
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
-
APA Corporation Expands Partnership with Palantir To Leverage AI Technology Across Their Oil and Gas Operations
-
"Princess Adachi Festival: A Celebration of Wishes" - December 18-19, 2024, in Kita-Senju!
-
Taylor Morrison Announces Date for Third Quarter 2024 Earnings Release and Webcast Conference Call
-
Ryder E-commerce Study Reveals In-Store Shopping Sentiment Up 21%
-
YieldMax™ ETFs Announces Distributions on Fund of Funds ETFs
-
INE Security Alert: 5 Ways to Implement Real-World Scenarios Into Cybersecurity Preparedness
-
Next Capital Promotes Luxury Project Samana Barari and Global Affiliate Program Amid Dubai Real Estate Boom
-
Calling Blockchain Enthusiasts: Bybit Launches BUIDL Apprenticeship Program to Nurture Emerging Talent in Crypto
-
Totalkredit and competition authorities reach agreement about Totalkredit partnership - Nykredit Realkredit A/S
-
Dotmatics Acquires Virscidian, Expanding Expertise in Analytical Chemistry and Chromatography and Mass Spectrometry
-
Target Hospitality Provides Business Update
-
Southwest Airlines Co. 2024 Investor Day
-
Senior Market Sales® Adds Visionary Mark T. Hunter to Executive Leadership
-
New data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis
-
24 Hour Melbourne Plumbers Announce the Importance of Regular Gutter Cleaning for a Home's Roof and Plumbing System
-
Take2 Elevate Announce How to Craft a Compelling Brand Identity Through Web Development
-
Merck Provides Update on Phase 3 KEYFORM-007 Trial Evaluating Investigational Fixed-Dose Combination of Favezelimab and Pembrolizumab for Patients With Previously Treated PD-L1 Positive Microsatellite
-
New Data Show Almirall´s EBGLYSS® (Lebrikizumab) Provided Sustained Disease Control for up to Three Years in More Than 80% of Adults and Adolescents With Moderate-to-severe Atopic Dermatitis
-
Ferguson Share Repurchase Program - Weekly Report
-
DNOW Announces Third Quarter 2024 Earnings Conference Call
-
Form 8.3 - Rightmove Plc
-
C12 Northern NJ to Host Final "The Sonrise Stories" Event of 2024
-
JR Bespoke Designs Reveal the Evolution of Timber Entertainment Units
-
Reykjavík Energy | Green Bond Auction September 25th
-
Form 8.3 - Keywords Studios Plc
-
Form 8.3 - Balanced Commercial Property Trust Limited
